AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2025
Dec 8, 2025
30826_dirs_2025-12-08_a4f2e82a-6256-43f7-81ec-fed14f592667.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2025-12-04
Reporting Person: Hunt Anthony (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | Common Stock | J | 2000 | — | Disposed | 98959 | Direct |
Footnotes
F1: Represents a transfer of shares for which the Reporting Person is a joint tenant with right of survivorship.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23